{
    "nctId": "NCT05098951",
    "briefTitle": "Acupuncture for Stiffness of Joint Related to Aromatase Inhibitors in Patients With Early-Stage Breast Cancer",
    "officialTitle": "Efficacy and Safety of Acupuncture for Relieving Stiffness of Joint Related to Aromatase Inhibitors in Patients With Early-Stage Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer, Stiffness of Hand, Not Elsewhere Classified",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 52,
    "primaryOutcomeMeasure": "The change in stiffness score as measured by the Western Ontario and McMasters Universities Osteoarthritis (WOMAC)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. History of stage I-III breast cancer and free of disease by clinical examination\n2. Postmenopausal or premenopausal with ovarian suppression\n3. Currently receiving aromatase inhibitors (Anastrozole, Letrozole, or Exemestane) treatment\n4. With joint stiffness attributed to the use of aromatase inhibitors\n5. Having had joint stiffness for at least 1 months\n6. Having had at least 15 days with stiffness in the preceding 30 days\n\nExclusion Criteria:\n\n1. Women with recurrent or metastatic breast cancer\n2. Women having finished chemotherapy or radiation therapy less than 1 months prior to enrollment\n3. Women with history of bleeding disorder\n4. Women with joint stiffness attributed to inflammatory arthritis, such as rheumatoid arthritis, spondy loarthritis and osteoarthritis\n5. Women having joint stiffness prior to AI treatment\n6. Women that have received treatment of any kind for joint stiffness within the last 3 months\n7. Women that have previously received the acupuncture treatment before for any reason",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}